KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Enterprise Value: 2009-2014

Historic Enterprise Value for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to $801.1 million.

  • Biocryst Pharmaceuticals' Enterprise Value rose 33.06% to $764.6 million in Q3 2015 from the same period last year, while for Sep 2015 it was $529.9 million, marking a year-over-year increase of 42.04%. This contributed to the annual value of $801.1 million for FY2014, which is 94.89% up from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Enterprise Value is $801.1 million, which was up 94.89% from $411.0 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Enterprise Value registered a high of $801.1 million during FY2014, and its lowest value of $36.7 million during FY2012.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Enterprise Value value was $411.0 million (recorded in 2013), while the average stood at $416.3 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Enterprise Value slumped by 60.77% in 2011 and then skyrocketed by 1,021.52% in 2013.
  • Biocryst Pharmaceuticals' Enterprise Value (Yearly) stood at $178.3 million in 2010, then crashed by 60.77% to $70.0 million in 2011, then tumbled by 47.61% to $36.7 million in 2012, then spiked by 1,021.52% to $411.0 million in 2013, then spiked by 94.89% to $801.1 million in 2014.